Our Solutions

March 2021

In this issue
The latest complimentary webinars, industry podcasts and articles, bioanalytical assays, and more!

The Altascientist

Exploring microsampling applications, benefits, and considerations in preclinical, clinical, and bioanalytical research during early phase drug development. Includes two case studies!

READ MORE

Making Early Phase Drug Development More Efficient
Engaging with a single partner through the critical early stages can make all the difference.

READ THE ARTICLE

Timely PK Analysis Supports Data-Driven Decisions
Exploring the benefits of including pharmacokinetic analysis between cohorts in first-in-human studies.

READ THE ARTICLE

Industry News
Keep up to date on the latest news from and about Altasciences.

READ MORE

CONTINUE READING

  • Webinars
    View the latest on-demand webinars and catch up on some of our favorites, including a new presentation on navigating the abuse potential evaluation of CNS-active drugs for European and American submissions. 
  • Podcasts
    HListen to discussions about the principles of the 3Rs in preclinical studies, large molecule bioanalysis, Altasciences’ unique approach to scientific project management, and research support services. 
  • Up Close and Personal with…
    Meet Dr. Gaetano Morelli, Chief Medical Officer at Altasciences.
  • Blog
    Learn more about protocol design concepts in Phase I ethnobridging clinical trials. 

LET'S STAY CONNECTED!

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.

 

Learn More

Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward.

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

You can unsubscribe at any time. For more details, please review our privacy policy.

Stay connected